Advert - Hospira

• Date posted
  01 August 2016
• Sanction
  Advertisement,
• Case number/s
  AUTH/2820/2/16 - Media criticism - Media/PMCPA Director v Hospira

For holding a meeting outside the UK for UK health professionals which was not a genuine advisory board, where its biosimilar medicines were promoted, Hospira was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Clause 9.1 - Failing to maintain high standards.

Clause 18.1 - Providing an inducement to prescribe or recommend Hospira medicines.

Clause 22.1 - Providing inappropriate hospitality.

Clause 23.1 - Engaging health professionals in other than genuine consultancy arrangements.

The full case report was published in the PMCPA August Code of Practice Review and it is available at www.pmcpa.org.uk.